Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.

Longest PW, Son YJ, Holbrook L, Hindle M.

Pharm Res. 2013 Jun;30(6):1608-27. doi: 10.1007/s11095-013-1001-z. Epub 2013 Mar 8.

2.

Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations.

Behara SR, Longest PW, Farkas DR, Hindle M.

J Pharm Sci. 2014 Feb;103(2):465-77. doi: 10.1002/jps.23775. Epub 2013 Dec 4.

3.

Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.

Zhu B, Young PM, Ong HX, Crapper J, Flodin C, Qiao EL, Phillips G, Traini D.

J Pharm Sci. 2015 Jul;104(7):2169-76. doi: 10.1002/jps.24458. Epub 2015 Apr 30.

PMID:
25931324
4.

Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.

Hassoun M, Ho S, Muddle J, Buttini F, Parry M, Hammond M, Forbes B.

Int J Pharm. 2015 Jul 25;490(1-2):360-7. doi: 10.1016/j.ijpharm.2015.05.028. Epub 2015 May 15.

PMID:
25987210
5.

Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications.

Behara SR, Farkas DR, Hindle M, Longest PW.

Pharm Res. 2014 Feb;31(2):360-72. doi: 10.1007/s11095-013-1165-6. Epub 2013 Aug 16.

6.
7.
8.

Dry powder inhaler device influence on carrier particle performance.

Donovan MJ, Kim SH, Raman V, Smyth HD.

J Pharm Sci. 2012 Mar;101(3):1097-107. doi: 10.1002/jps.22824. Epub 2011 Nov 17.

PMID:
22095397
9.

Development of high efficiency ventilation bag actuated dry powder inhalers.

Behara SR, Longest PW, Farkas DR, Hindle M.

Int J Pharm. 2014 Apr 25;465(1-2):52-62. doi: 10.1016/j.ijpharm.2014.01.043. Epub 2014 Feb 7.

10.

Powder, capsule and device: An imperative ménage à trois for respirable dry powders.

Schoubben A, Blasi P, Giontella A, Giovagnoli S, Ricci M.

Int J Pharm. 2015 Oct 15;494(1):40-8. doi: 10.1016/j.ijpharm.2015.08.012. Epub 2015 Aug 5.

PMID:
26255220
11.

Understanding the Different Effects of Inhaler Design on the Aerosol Performance of Drug-Only and Carrier-Based DPI Formulations. Part 1: Grid Structure.

Leung CM, Tong Z, Zhou QT, Chan JG, Tang P, Sun S, Yang R, Chan HK.

AAPS J. 2016 Sep;18(5):1159-67. doi: 10.1208/s12248-016-9922-1. Epub 2016 May 9.

PMID:
27161214
12.

Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.

Longest PW, Golshahi L, Behara SR, Tian G, Farkas DR, Hindle M.

J Aerosol Med Pulm Drug Deliv. 2015 Jun;28(3):189-201. doi: 10.1089/jamp.2014.1158. Epub 2014 Sep 5.

13.

Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.

Le VN, Robins E, Flament MP.

Eur J Pharm Biopharm. 2012 Apr;80(3):596-603. doi: 10.1016/j.ejpb.2011.12.004. Epub 2011 Dec 14.

PMID:
22198291
14.

The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.

Young PM, Wood O, Ooi J, Traini D.

Int J Pharm. 2011 Sep 15;416(1):129-35. doi: 10.1016/j.ijpharm.2011.06.020. Epub 2011 Jun 17.

PMID:
21708238
15.

Particle aerosolisation and break-up in dry powder inhalers: evaluation and modelling of impaction effects for agglomerated systems.

Wong W, Fletcher DF, Traini D, Chan HK, Crapper J, Young PM.

J Pharm Sci. 2011 Jul;100(7):2744-54. doi: 10.1002/jps.22503. Epub 2011 Mar 1.

PMID:
21360707
16.

Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks.

Kinnunen H, Hebbink G, Peters H, Shur J, Price R.

AAPS PharmSciTech. 2014 Aug;15(4):1009-20. doi: 10.1208/s12249-014-0108-9. Epub 2014 May 16.

17.

Applications of capsule dosing techniques for use in dry powder inhalers.

Edwards D.

Ther Deliv. 2010 Jul;1(1):195-201. Review.

PMID:
22816126
18.

What is the role of particle morphology in pharmaceutical powder aerosols?

Chan HK.

Expert Opin Drug Deliv. 2008 Aug;5(8):909-14. doi: 10.1517/17425247.5.8.909 . Review.

PMID:
18712999
19.

Deagglomeration of dry powder pharmaceutical aerosols.

Voss A, Finlay WH.

Int J Pharm. 2002 Nov 6;248(1-2):39-50.

PMID:
12429458
20.

Advances in device and formulation technologies for pulmonary drug delivery.

Chan JG, Wong J, Zhou QT, Leung SS, Chan HK.

AAPS PharmSciTech. 2014 Aug;15(4):882-97. doi: 10.1208/s12249-014-0114-y. Epub 2014 Apr 12. Review.

Supplemental Content

Support Center